Clinical Trial Update: Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study of Rituximab for refractory inflammatory myopathies and refractory myasthenia gravis, with the trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis
• Myositis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myositis, Myasthenia Gravis | Phase 2 | Status: COMPLETED